Premier Alternatives

Cytogel Pharma

Darien, CT · Founded 2006 · Privately Held (backing)

Operator of a bio-pharmaceutical company intended to assist with the discovery and development of safe and innovative treatments to finally resolve moderate to severe pain. Cytogel Pharma is based in Darien, CT and was founded in 2006. It was valued at $47 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $32.8 million across 4 recorded rounds; the latest was a $1.8 million seed round in Jun 2023.

PMV mark · valuation
$47.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$32.8M
Last round
Seed Round
Jun 2023

Cytogel Pharma key facts

as of Oct 2026
  • Operator of a bio-pharmaceutical company intended to assist with the discovery and development of safe and innovative treatments to finally resolve moderate to severe pain.
  • Cytogel Pharma is valued at approximately $47.0M as of Oct 2026, set at its later-stage round, Oct 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $32.8M across 4 recorded rounds; the latest was Seed Round ($1.8M) in Jun 2023.
  • Notable investors include New Ground Ventures, Westway Capital, Centripetal Capital Partners, Cytogel Venture, John Fernandes.
  • Cytogel Pharma has filed 14 Form Ds with the SEC since 2010, most recently Oct 2024 ($1.8M sold to 18 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$47.0M

Valued at $47.0M at its later-stage round, Oct 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Cytogel Pharma with a free account
  • ·Watch Cytogel Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cytogel Pharma funding rounds

4 rounds
Jun 2023Seed Round$1.8MSEC filing▮
Sep 2019Seed Round$957KSEC filing▮
Jan 2015Seed Round$2.7MSEC filing▮
Feb 2013Seed Round$750KSEC filing▮
Full funding history →

Cytogel Pharma valuation

Cytogel Pharma was valued at $47 million at its later-stage round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Cytogel Pharma raised?

Cytogel Pharma has raised $32.8 million in total; 4 of its rounds are on record, from 2013 on. The largest on record was a $956,905 seed round in Sep 2019; the most recent was a $1.8 million seed round in Jun 2023.

Cytogel Pharma has filed 14 Form Ds with the SEC since 2010, most recently in Oct 2024 ($1.8 million sold to 18 investors).

Cytogel Pharma investors

5 investors are on record for Cytogel Pharma, including New Ground Ventures, Westway Capital, Centripetal Capital Partners and Cytogel Venture. The seed round in Jun 2023 drew 18 investors.

About Cytogel Pharma

Operator of a bio-pharmaceutical company intended to assist with the discovery and development of safe and innovative treatments to finally resolve moderate to severe pain. The company offers significant potential both as platform technologies, value product candidates, and drug delivery hydrogels that represent a breakthrough in the treatment of pain, enabling patients to get treatment properly, resulting in a likelihood of successful treatment.

Sector
Healthcare
HQ
Darien, CT, United States
Founded
2006
Employees
9
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.